Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' Natraceutical, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Natraceutical, S.A. since January 2007.
– Provides intelligence on Natraceutical, S.A.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by Natraceutical, S.A. and its subsidiaries since 2007. – Information about key financial and legal advisors for Natraceutical, S.A.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes Natraceutical, S.A.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Natraceutical, S.A.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about Natraceutical, S.A.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
KEY FINDINGS The Europe immunoglobulin market is predicted to progress with a CAGR of 6.90% across the forecast period of 2022 to 2030. The regional market’s growth is fuelled by supportive government initiatives for immunoglobulin and plasma donation, the prevalence of different immunodeficiency diseases, and the growth...
The Europe Human Microbiome Market would witness market growth of 31.7% CAGR during the forecast period (2022-2028). The increased focus on the development of human Microbiome treatment is driving the market growth. Human microbiomes have also established themselves as viable target for therapeutic research. The growing number of market...
400 pages •
By The Business Research Company
• Dec 2021
Major players in the non-animal alternatives testing are MatTek Corporation, Cyprotex, Emulate Inc, BioIVT, Bio-Rad Laboratories, GE Healthcare, SGS SA, BioIVT, Abbott Laboratories and Gentronix Limited. The global non-animal alternatives testing market is expected to grow from $1.63 billion in 2021 to $1.78 billion in 2022 at a compound...
106 pages •
By Roots Analysis Private Ltd.
• Aug 2021
INTRODUCTION The “Progressive Supranuclear Palsy (PSP) Therapies Market by Type of Treatment (Curative and Palliative / Symptomatic), and Key Geographical Regions (US, UK, Germany, France, Italy and Spain): Industry Trends and Global Forecasts, 2021-2030” report features an extensive study on molecules being evaluated in...
The Latin America, Middle East and Africa Enzymes Market would witness market growth of 9.33% CAGR during the forecast period (2021-2027). Catalytic hydrolysis of starch requires amylase and cellulase in order to create sugar. The growth of the global enzymes market would be driven by the rising utilization of carbohydrases as an ingredient...
The Latin America, Middle East and Africa Alginate Market would witness market growth of 8.83% CAGR during the forecast period (2020-2026). Development of the food & beverage sector in BRICS and the Middle East due to expanding domestic consumption is expected to augment the consumption of alginates. The rising demand for convenience...
Generics Global Industry Guide 2015-2024 Summary Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including...
Generics Global Group of Eight (G8) Industry Guide 2015-2024 Summary The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading...
Pharmaceuticals Global Industry Guide 2015-2024 Summary Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players...
The Latin America, Middle East and Africa Moringa Ingredients Market would witness market growth of 12.2% CAGR during the forecast period (2020-2026). Moringa, as a rich source of some macro and micronutrients, is gaining prominence as an ingredient in the manufacture of food supplements. Moringa seed leaves and flowers are commonly...
United Arab Emirates
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.